Inventor

Kang Ting

Inventor
Beverly Hills, CA, US

Overview

32→
Patents
2006–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 32 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
A61KPreparations for medical, dental or toiletry purposes21%
C07KPeptides14%
A61LMethods or apparatus for sterilising materials or objects in general10%
C12NMicroorganisms or enzymes9%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
Y10TTechnical subjects covered by former us classification4%
A61FFilters implantable into blood vessels3%
A61MDevices for introducing media into, or onto, the body3%
A61NElectrotherapy2%
PatentTitleYear
11,033,605Methods of promoting angiogenesis in tissue with fibromodulin202110,729,747Methods and compositions for modulating myofibroblast activities202010,716,878Nanoparticle-based scaffolds and implants, methods for making the same, and applications thereof202010,675,307Compositions comprising perivascular stem cells and nell-1 protein202010,346,331Method and apparatus for data detection and event capture201910,335,458Pharmaceutical compositions for treating or preventing bone conditions201910,279,010Methods and compositions for modulating myofibroblast activities201910,190,097Method and composition for inducing human pluripotent stem cells201910,177,753Techniques for generating pulse-width modulation data20199,974,828Isoform nell-1 peptide20189,885,014'Re-conditioned serum-free culture medium composition obtained by culturing mammalian cells in Fibromodulin'20189,744,214'Methods and compositions for modulating myofibroblast activities'20179,730,965'Perivascular stem cell composition for bone'20179,598,480'Recombinant NEL-like (NELL) protein production'20179,549,954'Method and composition for inducing human pluripotent stem cells'20179,511,115'Pharmaceutical compositions for treating or preventing bone conditions'20169,447,155'Isoform Nell-1 peptide'20169,409,963'Fibromodulin peptide'20169,301,976'Compositions comprising perivascular stem cells and nell-1 protein'20169,089,677'Transcutaneous multimodal delivery system (TMDS)'20158,207,120'NELL-1 enhanced bone mineralization'20128,053,412'NELL-1 peptides'20118,048,646'NELL peptide expression systems and bone formation activity of NELL peptide'20118,044,026'Composition for promoting cartilage formation or repair comprising a NELL gene product and method of treating cartilage-related conditions using such composition'20117,884,066'NELL-1 enhanced bone mineralization'20117,833,968'Pharmaceutical compositions for treating or preventing bone conditions'20107,807,787'NELL-1 peptide'20107,776,361'NELL-1 enhanced bone mineralization'20107,691,607'Expression system of NELL peptide'20107,687,462'Composition for promoting cartilage formation or repair comprising a nell gene product and method of treating cartilage-related conditions using such composition'20107,544,486'Nell peptide expression systems and bone formation activity of nell peptide'20097,052,856'NELL-1 enhanced bone mineralization'2006

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2006–2021Patents assigned to UNIV CALIFORNIA (30)· patent assignee history
2006–2021Based in Beverly Hills, CA, US· patent location history
2012–2017Patents assigned to TING KANG (7)· patent assignee history
2015–2017Patents assigned to SOO B CHIA (4)· patent assignee history
2016Patents assigned to SOO CHIA (2)· patent assignee history
2019Patents assigned to ALTERA CORP (2)· patent assignee history
2019Based in Bayan Lepas, MY· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV CALIFORNIA302006–2021
TING KANGself72012–2017
SOO B CHIA42015–2017
ALTERA CORP22019
SOO CHIA22016
Locations
LocationPatentsSpan
Beverly Hills, California, US302006–2021
Bayan Lepas, MY22019